By Anil Oza, STAT The second Trump administration has created upheaval in the biomedical research community. Widespread grant terminations, fast-changing policy changes, and proposals to downsize federal spending have created unease among a group that has largely been able to lean on the government as a partner. In late May, another move caught the attention…